Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Before the following is removed from the Yahoo message board

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Jul 08, 2021 7:11pm

190 Views

Post# 33519151

RE:RE:RE:Before the following is removed from the Yahoo message board

3 hours ago

Armed ??? sorry I just don't have the time to play with your trivial spewings at the moment, I did and I did, but poof gone. bye Bye....

Guidelines

3 hours ago

Kenny, I lump you with the others to pull your tail. As far as investment in this turd we are at even ground. So relax. As far as you being the self flagellating and enjoying it snowflake buddy of mine, admit it Kenny. You pledged part of riches from ONCY success(:)))) to wiping the whiteness off your laughing face. Be as it may, I still like you little buddy.